Candela’s brand values of Science, Results, and Trust guide its commitment to clinically proven results to strengthen the longstanding partnerships established with physicians, their practices and the patients they treat.
Established in 1970, Candela is a leading US-based global medical aesthetic device company with headquarters in Marlborough, Massachusetts. Candela Medical develops and manufactures medical aesthetic laser, IPL, and RF microneedling machines which come with extendable technical, clinical, and marketing support. We also provide flexible service maintenance plans, educational programs and training workshops with the industry professionals. The company’s innovative technology focuses on the medical aesthetic and beauty treatments for the face and body, our devices are sold primarily to plastic surgeons, dermatologists, hospitals, and medical spas in many countries in the world.
Candela markets, services and supports its products in nearly 100 countries, with offices in North America, Israel, France, Germany, Italy, Spain, UK, Australia, China, Japan, Hong Kong, and distributors worldwide.
On the July 17th, 2017, Candela announced the successful completion of its acquisition by an affiliate of funds advised by Apax Partners. Apax Partners is a leading global private equity advisory firm.
Candela’s focus is on their customers’ success by building on the strength of Candela’s brands, the technology behind its products, and the high quality of the company’s engineering and product development organization.